Sign In
Home
About Us
Benefits
Pricing
Krixos Global Intel
Krixos
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Krixos Health:
Sign Up Now:
Your email:
or call us on: +43 (0)1 27 63 015
or email:
subscribe@krixos.com
Most viewed
1.
A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study
2.
New Proteomics blood test unlocks better oesophageal cancer detection
3.
FDA approves darolutamide for metastatic castration-sensitive prostate cancer
4.
Poll: Majority of U.S. Adults Say Democrats Actively Tried to 'Conceal' Reality of Biden's Declining Health
5.
Clinical efficacy of laparoscopic radical cystectomy with intracorporeal urinary diversion and an analysis of factors influencing complications
6.
NRG Oncology study shows the addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence in patients whose axillary nodes convert from positive to negative following neoadjuvant chemotherapy
7.
Polls close and count begins to replace late MSP in Holyrood by-election
8.
Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
9.
Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis
10.
Grape seed proanthocyanidins improve lymphatic drainage and blood perfusion in secondary lymphedema models
Last updated at 16:25 GMT
Hot News Makers
Health/Pharma Companies
EW Healthcare Partners
10954.36
Alibaba Health
9065.79
Aperture Venture Partners
7390.89
Omada Health
7275.29
FinnGen
5708.13
Apellis Pharmaceuticals
5601.44
Longitude Capital
5211.77
Johnson & Johnson
4755.57
UK Health Security Agency
4735.08
NHS
4553.57
Drugs, Treatments, Trials
Trastuzumab
8253.77
UGN-102
7623.06
Paclitaxel
6404.95
Capecitabine
5825.49
Fentanyl
5062.07
Nab-Paclitaxel
3206.28
Calquence
2953.12
Melatonin
2943.01
Temozolomide
2785.67
Isoflurane
2360.87
Last updated at 16:10 GMT